U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 22:26:30 GMT 2025
Edited
by admin
on Mon Mar 31 22:26:30 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
8EJE45ZR0I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AXL ONCOGENE
Preferred Name English
TYROSINE-PROTEIN KINASE RECEPTOR UFO
Common Name English
TYROSINE KINASE RECEPTOR UFO (HUMAN GENE AXL)
Common Name English
UFO
Common Name English
Code System Code Type Description
CAS
1432759-18-6
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
ALTERNATIVE
WIKIPEDIA
AXL RECEPTOR TYROSINE KINASE
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
CAS
1432761-16-4
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
EC (ENZYME CLASS)
EC 2.7.10.1
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
FDA UNII
8EJE45ZR0I
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
UNIPROT
P30530
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
PHAROS
P30530
Created by admin on Mon Mar 31 22:26:30 GMT 2025 , Edited by admin on Mon Mar 31 22:26:30 GMT 2025
PRIMARY
From To
1_31 1_92
1_135 1_180
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_18
N 1_132
N 1_173
N 1_314
N 1_320
N 1_376
Related Record Type Details
Structure of 5-PYRIMIDINECARBOXAMIDE, N-(4-(4-AMINO-7-(1-(2-METHYL-1-OXOPROPYL)-4-PIPERIDINYL)PYRROLO(2,1-F)(1,2,4)TRIAZIN-5-YL)PHENYL)-1,2,3,4-TETRAHYDRO-1-(1-METHYLETHYL)-2,4-DIOXO-3-(2-PYRIDINYL)-
INHIBITOR -> TARGET
Structure of MERESTINIB
INHIBITOR -> TARGET
Structure of CEP-40783
INHIBITOR -> TARGET
Structure of SU-11652
INHIBITOR -> TARGET
Structure of K252A
INHIBITOR -> TARGET
Structure of TSN-084
INHIBITOR -> TARGET
Structure of Zanzalintinib
INHIBITOR -> TARGET
IC50
Structure of DUBERMATINIB
INHIBITOR -> TARGET
Structure of INDIRUBIN E804
INHIBITOR -> TARGET
Structure of BOSUTINIB
INHIBITOR -> TARGET
ENAPOTAMAB
LIGAND->TARGET
Structure of SITRAVATINIB
INHIBITOR -> TARGET
Structure of K-00546
INHIBITOR -> TARGET
Structure of Crizotinib
INHIBITOR -> TARGET
MECBOTAMAB VEDOTIN
LIGAND->TARGET
Structure of S-49076
INHIBITOR -> TARGET
TILVESTAMAB
INHIBITOR -> TARGET
Structure of BEMCENTINIB
INHIBITOR -> TARGET
Structure of 6H-Indeno[1,2-e]tetrazolo[1,5-b][1,2,4]triazin-6-one
INHIBITOR -> TARGET
Structure of N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluoro-2-methylphenyl)pyrazole-3-carboxamide
INHIBITOR -> TARGET
ENAPOTAMAB VEDOTIN
CONJUGATED TOXIN->TARGET
MECBOTAMAB
LIGAND->TARGET
Structure of SB-218078
INHIBITOR -> TARGET
Structure of JNJ-28312141 FREE BASE
INHIBITOR -> TARGET
Structure of STAUROSPORINE
INHIBITOR -> TARGET
Structure of BMS-777607
INHIBITOR -> TARGET
Structure of SUNITINIB
INHIBITOR -> TARGET
Structure of N-[4-[2-Amino-5-[4-[(2R)-1,4-dioxan-2-ylmethoxy]-3-methoxyphenyl]-3-pyridinyl]-3-fluorophenyl]-1?,4?-dihydro-5-methyl-4?-oxo-1?-[(tetrahydro-2H-pyran-4-yl)methyl][2,3?-bipyridine]-5?-carboxamide
INHIBITOR -> TARGET
Structure of GILTERITINIB
INHIBITOR -> TARGET
Structure of BMS-794833
INHIBITOR -> TARGET
IC50
Structure of SLC-391
INHIBITOR -> TARGET

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_678] [1_754] [1_796] [1_841] TYROSINE TYROSINE O-PHOSPHATE 2R86C98KDX
AMINO ACID SUBSTITUTION [1_859] SERINE DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966